share_log

港股异动 | 力鸿检验(01586)涨超6% 业绩+估值双重利好下 机构认为检测板块有望迎来“戴维斯双击”

Changes in Hong Kong stocks | Lihong Test (01586) rose more than 6% under the dual benefits of performance+valuation, institutions believe the testing sector is expected to face a “double attack by Davis”

Zhitong Finance ·  Jul 27, 2023 11:21

The Zhitong Finance App learned that Lihong Test (01,586) rose more than 6% and rose 6.49% at the time of publication to HK$1.64, with a turnover of HK$1.26 million.

According to the news, on July 27, the National Development and Reform Commission and other departments issued a notice on promoting the healthy development of the modern coal chemical industry. Among them, it is mentioned that the scale of modern coal chemical production capacity and new coal consumption are strictly controlled, and that the total conversion volume of 20 million tons of new coal added to each demonstration zone during the “13th Five-Year Plan” period as specified in the “Modern Coal Chemical Industry Innovation and Development Layout Plan” will not continue. Modern coal chemical projects that really need to be built should ensure a stable supply of coal, give priority to completing the tasks of securing the supply of coal for power generation and heating, and not to reduce coal supply for the construction of modern coal chemical projects.

According to reports, the company is an international third-party independent inspection and testing company listed on the main board of the Hong Kong Stock Exchange. It is the first domestic third-party inspection and certification agency listed in Hong Kong. In the energy and bulk fields of coal, petroleum and petrochemicals, electricity, mineral products, etc., we provide inspection, testing, measurement, certification and related services to more than 5,000 customers around the world. The network covers major domestic and Asia-Pacific trade hubs.

Tianfeng Securities released a research report stating that the testing industry's business area covers all walks of life, and its development is highly correlated with macroeconomic levels. Under the dual benefits of performance+valuation, the testing sector is expected to face a “double attack by Davis.” On the one hand, in terms of performance, sector performance in 2020-2022 is under pressure, and with the epidemic prevention and control entering a new stage, economic growth is steadily recovering, which is expected to drive a recovery in sector performance; on the other hand, in terms of valuation levels, the 2022 sector has always hovered at a low level, while various industries have gradually picked up since the start of 2023, the domestic industry resumption rate has been rising steadily, and sector valuations are expected to return to a reasonable level.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment